(CALP, PMIC, MSHL) CRWENewswire Stocks In Action

Good Thursday Morning, Its September 8th, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. According to reports, PerkinElmer has agreed to buy Caliper Life Sciences Incorporated - symbol CALP - for $10.50 per share or $600 million. This aquisition will help PerkinElmer broaden its reach in molecular imaging and genomic detection technologies. ACE Limited has entered into a definitive agreement to acquire Penn Millers Holding Corporation - symbol PMIC - for $107 million or $20.50 per share in cash. and finally; Marshall Edwards Incorporated - symbol MSHL - has initiated a Phase I clinical trial of the Company’s lead product candidate ME-143 in patients with refractory solid tumors. According to the company, In pre-clinical studies, ME-143 has demonstrated potent activity against a number of tumor cell lines. Thanks for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Sara Bryant